STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more
And so, another working week will soon draw to a close. Not a moment too…
Author: STAT
Can GLP-1 drugs help with type 1 diabetes?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Why these health tech leaders are making a risky bet, openly backing Trump or Harris
Silicon Valley startup founders and venture capital investors are picking a side in this year’s…
STAT+: Insurers went all-in on Medicare Advantage. Now, some are scaling back
For years, health insurers battled to gain market share in the lucrative privatized Medicare program….
Opinion: STAT+: What does the presidential election mean for ICHRA and the health insurance market?
Over the past two presidential administrations, the health care market has changed dramatically with the…
STAT+: A new drug offers a rare option for brain cancer treatment — and inspires hopes for more
For more cancer coverage, sign up for STAT’s pop-up newsletter focused on this weekend’s European…
Opinion: Compounded semaglutide is an ill-defined public health crisis
I first met Jane (not her real name, of course) on a Friday afternoon in…
STAT+: How efforts to cancel medical debt could wind up benefitting hospitals
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids
What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in…
Cause of Missouri H5 bird flu case remains a mystery, CDC says
Disease investigators have not been able to determine how a person in Missouri with no…
STAT+: ‘Put him in jail.’ Steward CEO de la Torre skips hearing, now Congress is poised to hold him in contempt
Lawmakers in Washington turned their focus to the Steward Health Care bankruptcy scandal on Thursday,…
FDA is taking on tampons and ‘misleading’ ads starring Serena Williams
Good morning! I’ve decided today is the day that I must tell you about my…
STAT+: Can iTeos and GSK solve TIGIT’s troubles?
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
Moderna cuts spending, and Sarepta’s ‘curse’ on Califf
Good morning. If you’re following the European Society for Medical Oncology meeting that starts tomorrow,…
STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more
Rise and shine, everyone, another busy day is on the way. However, this is also…
STAT+: Gilead’s twice-yearly antiviral protects against HIV infection in second large trial
Gilead said Thursday that its twice-yearly antiviral reduced the risk of HIV infections by 96%…
.jpg)
STAT+: Moderna touts research progress as it cuts R&D spending by $1.1 billion
Moderna said Thursday it would cut its annual spending on research and development by 23%,…
STAT+: Apple will offer millions of AirPod users a hearing aid. Can it convince them to use it?
After years of dabbling in hearing health, Apple earlier this week went all-in, announcing that…
Opinion: STAT+: How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma
In a rare display of bipartisan agreement, Congress is getting serious about addressing China’s influence…
STAT+: A rare disease program, portrayed as both lifeline and pharma handout, is set to expire
After his son Michael was diagnosed with a devastating, ultra-rare disease in 2019, Terry Pirovolakis…
Five takeaways from Congress’ hearing on overhauling organ transplant system
WASHINGTON — On Wednesday, two transplant doctors, one watchdog and a nephrologist-turned-advocate sat before members…
A presidential debate, GLP-1s for kids, and ultra-processed foods research
Good morning! Today STAT is publishing the final installment in the “Embedded Bias” series. My…
STAT+: Key Senate Republican throws cold water on Affordable Care Act repeal, site-neutral payment policy
WASHINGTON — A key Senate Republican dismissed the idea that the Affordable Care Act can…
Blood cell counts have unfairly kept Black and Middle Eastern people from clinical trials, study says
One of the most important measurements for cancer patients is the neutrophil count. Certain cancer…
STAT+: FDA commissioner: Health systems have to ‘step up’ on AI regulation or will ‘end up holding the bag’
WELLESLEY, Mass. — Amid heated discussions on how artificial intelligence should be regulated and who…
STAT+: FDA scolds AbbVie over ‘misleading’ TV ad for a migraine pill featuring Serena Williams
The U.S. Food and Drug Administration has scolded AbbVie for making false and misleading claims…
STAT+: ‘Sarepta’s like a curse on me’: FDA commissioner dismisses controversy over approval
WELLESLEY, Mass. — At an event with journalists Tuesday outside of Boston, U.S. Food and…
STAT+: Pharmalittle: We’re reading about a Novo weight loss study, a GSK vaccine failure, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
Eli Lilly releases new data on weekly insulin
Want to stay on top of the science and politics driving biotech today? Sign up to get…
How a government scientist is pushing to supersize research into ultra-processed foods
CHICAGO — The last place you might have expected Kevin Hall to make a plea…
STAT+: How hospitals could make money off of Kamala Harris’ medical debt relief plan
WASHINGTON — The largest health system in North Carolina simply wasn’t interested in canceling its…
Opinion: The surgeon general’s warning on parental mental health doesn’t go far enough
Surgeon General Vivek Murthy’s latest warning unearths concerning statistics about the mental health and well-being…
STAT+: Q&A: For this South Dakota health system, leaning into telehealth means learning ‘webside’ manner
Fighting a massive snowstorm to get to the doctor in the Dakotas is an unpleasant…
Opinion: Why so many patients are confused about CPR and do-not-resuscitate orders
When a patient is admitted to the hospital in the U.S., there’s a standard question…
STAT+: After FDA rejection, Sanofi and Regeneron’s Dupixent succeeds in late-stage trial of chronic hives
Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with chronic spontaneous urticaria, an inflammatory…
Trump admits he still doesn’t have an Affordable Care Act replacement plan
WASHINGTON — Eight years after he was elected president on a promise to repeal and…
AI threatens to cement racial bias in clinical algorithms. Could it also chart a path forward?
PROVIDENCE, R.I. — In a cavernous converted chapel at Brown University, physician and data scientist…
Trump struggles to find an abortion answer
WASHINGTON — Former President Trump is still struggling to land on an abortion answer that…
STAT+: Elevance buys IU Health’s insurance company
Elevance Health, the parent of more than a dozen state Blue Cross Blue Shield plans,…
Obesity drug worked in children ages 6 to 12, study says, raising hopes and concerns
The first late-stage trial of a GLP-1 drug in young children with obesity showed the…
STAT+: Novo Nordisk’s amylin pill leads to substantial weight loss in early study
Novo Nordisk on Tuesday reported that its new obesity pill that targets the amylin hormone…
The health care issues to watch in tonight’s presidential debate between Kamala Harris and Donald Trump
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Key lawmakers are wary of giving FDA more cash to crack down on e-cigs
WASHINGTON – Powerful House lawmakers from both parties are skeptical of the Food and Drug…
Health care AI investment hype, and value-based-care model for mental health apps
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
Morning Rounds: Apple Watch takes on sleep apnea and tonight’s presidential debate
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning…
Five biotech news stories you need to read today
Morning! Today, we’ll keep riding the bispecific wave, and tell you what Verily and FDA…
STAT+: Pharmalittle: We’re reading about a Roivant deal, limited access to medicines and more
The U.S. House of Representatives passed a bill by 306 to 81 votes to make…
STAT+: Pharma is still struggling to widen access to medicines — and reach patients — in low- and middle-income countries
Amid calls to expand access to medicines in low- and middle-income countries, a new analysis…
STAT+: Viridian drug achieves study goals as treatment for thyroid eye disease
Viridian Therapeutics said Tuesday that an experimental treatment improved the signs and symptoms of thyroid…
STAT+: Roivant acquires drug for pulmonary hypertension from Bayer
For months, investors have been asking Roivant Sciences chief executive Matt Gline to reveal the…